Opinion|Videos|April 28, 2025

FDA-Approved and Pipeline Treatments for Elevated Lp(a) Levels

Experts discuss FDA-approved therapies for high lipoprotein(a) [Lp[a]) levels, their benefits and shortcomings, the frequency of their use in health plans, emerging therapies in the pipeline, and the expected timeline for associated data release.

Video content above is prompted by the following:

  • What therapies for high Lp(a) levels are currently approved by the FDA?
  • What benefits and shortcomings (eg, cost, time) are associated with this therapy?
  • How frequently is this therapy used in the health plans you work with?
  • What therapies are in the pipeline?
  • When do we expect associated data to be released?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.


Latest CME

Brand Logo

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo